These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 18537968)

  • 21. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
    Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia.
    Jost E; do O N; Wilop S; Herman JG; Osieka R; Galm O
    Leuk Res; 2009 Mar; 33(3):443-9. PubMed ID: 18757096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased expression and aberrant hypermethylation of the SFRP genes in human gastric cancer.
    Kinoshita T; Nomoto S; Kodera Y; Koike M; Fujiwara M; Nakao A
    Hepatogastroenterology; 2011; 58(107-108):1051-6. PubMed ID: 21830441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer.
    Cheng YY; Yu J; Wong YP; Man EP; To KF; Jin VX; Li J; Tao Q; Sung JJ; Chan FK; Leung WK
    Br J Cancer; 2007 Oct; 97(7):895-901. PubMed ID: 17848950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia.
    Pehlivan M; Sercan Z; Sercan HO
    Leuk Res; 2009 Aug; 33(8):1062-7. PubMed ID: 19118898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias.
    Chim CS; Wong AS; Kwong YL
    Ann Hematol; 2003 Dec; 82(12):738-42. PubMed ID: 14513284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma.
    Takagi H; Sasaki S; Suzuki H; Toyota M; Maruyama R; Nojima M; Yamamoto H; Omata M; Tokino T; Imai K; Shinomura Y
    J Gastroenterol; 2008; 43(5):378-89. PubMed ID: 18592156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer.
    Fukui T; Kondo M; Ito G; Maeda O; Sato N; Yoshioka H; Yokoi K; Ueda Y; Shimokata K; Sekido Y
    Oncogene; 2005 Sep; 24(41):6323-7. PubMed ID: 16007200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.
    Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ
    Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma.
    Chim CS; Pang R; Fung TK; Choi CL; Liang R
    Leukemia; 2007 Dec; 21(12):2527-36. PubMed ID: 17882284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors.
    Pannone G; Bufo P; Santoro A; Franco R; Aquino G; Longo F; Botti G; Serpico R; Cafarelli B; Abbruzzese A; Caraglia M; Papagerakis S; Lo Muzio L
    Oncol Rep; 2010 Oct; 24(4):1035-41. PubMed ID: 20811686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent concomitant epigenetic silencing of SOX1 and secreted frizzled-related proteins (SFRPs) in human hepatocellular carcinoma.
    Shih YL; Hsieh CB; Yan MD; Tsao CM; Hsieh TY; Liu CH; Lin YW
    J Gastroenterol Hepatol; 2013 Mar; 28(3):551-9. PubMed ID: 23215838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor.
    Qi J; Zhu YQ; Luo J; Tao WH
    World J Gastroenterol; 2006 Nov; 12(44):7113-7. PubMed ID: 17131472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas.
    Götze S; Wolter M; Reifenberger G; Müller O; Sievers S
    Int J Cancer; 2010 Jun; 126(11):2584-93. PubMed ID: 19847810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic inactivation of the CIP/KIP cell-cycle control pathway in acute leukemias.
    Chim CS; Wong AS; Kwong YL
    Am J Hematol; 2005 Dec; 80(4):282-7. PubMed ID: 16315255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant methylation of secreted apoptosis-related protein 2 (SARP2) in pure pancreatic juice in diagnosis of pancreatic neoplasms.
    Watanabe H; Okada G; Ohtsubo K; Yao F; Jiang PH; Mouri H; Wakabayashi T; Sawabu N
    Pancreas; 2006 May; 32(4):382-9. PubMed ID: 16670620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypermethylation of secreted frizzled-related proteins predicts poor prognosis in non-M3 acute myeloid leukemia.
    Guo H; Zhang TJ; Wen XM; Zhou JD; Ma JC; An C; Zhang W; Xu ZJ; Lin J; Qian J
    Onco Targets Ther; 2017; 10():3635-3644. PubMed ID: 28790854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
    Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
    Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypermethylation of Wnt antagonist gene promoters and activation of Wnt pathway in myelodysplastic marrow cells.
    Masala E; Valencia A; Buchi F; Nosi D; Spinelli E; Gozzini A; Sassolini F; Sanna A; Zecchi S; Bosi A; Santini V
    Leuk Res; 2012 Oct; 36(10):1290-5. PubMed ID: 22742816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.